Demyelination after anti-TNF therapy: Who is at risk?
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
European Crohn's and Colitis Organisation
2020
|
_version_ | 1797091788812451840 |
---|---|
author | Williams, I Uhlig, HH |
author_facet | Williams, I Uhlig, HH |
author_sort | Williams, I |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T03:37:32Z |
format | Journal article |
id | oxford-uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3b |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T03:37:32Z |
publishDate | 2020 |
publisher | European Crohn's and Colitis Organisation |
record_format | dspace |
spelling | oxford-uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3b2022-03-27T05:27:03ZDemyelination after anti-TNF therapy: Who is at risk?Journal articlehttp://purl.org/coar/resource_type/c_b239uuid:bccb9835-7ed3-45a4-bd07-e1880d8ede3bEnglishSymplectic ElementsEuropean Crohn's and Colitis Organisation2020Williams, IUhlig, HH |
spellingShingle | Williams, I Uhlig, HH Demyelination after anti-TNF therapy: Who is at risk? |
title | Demyelination after anti-TNF therapy: Who is at risk? |
title_full | Demyelination after anti-TNF therapy: Who is at risk? |
title_fullStr | Demyelination after anti-TNF therapy: Who is at risk? |
title_full_unstemmed | Demyelination after anti-TNF therapy: Who is at risk? |
title_short | Demyelination after anti-TNF therapy: Who is at risk? |
title_sort | demyelination after anti tnf therapy who is at risk |
work_keys_str_mv | AT williamsi demyelinationafterantitnftherapywhoisatrisk AT uhlighh demyelinationafterantitnftherapywhoisatrisk |